跳至主要内容
临床试验/ACTRN12611000917932
ACTRN12611000917932
尚未招募
3 期

Multicentre randomised controlled trial in preterm infants 29-32 weeks gestation on continuous positive airway pressure of the effect of minimally-invasive surfactant therapy in comparison to standard care (continuation of CPAP) on the duration of respiratory support (all hours of intubation, nasal CPAP and high flow nasal cannula).

Menzies Institute of Medical Research, University of Tasmania0 个研究点目标入组 454 人2011年8月26日

概览

阶段
3 期
干预措施
未指定
疾病 / 适应症
未指定
发起方
Menzies Institute of Medical Research, University of Tasmania
入组人数
454
状态
尚未招募
最后更新
6年前

概览

简要总结

暂无简介。

注册库
who.int
开始日期
2011年8月26日
结束日期
待定
最后更新
6年前
研究类型
Interventional
性别
All

研究者

发起方
Menzies Institute of Medical Research, University of Tasmania

入排标准

入选标准

  • 1\. Gestational age 29\-32 completed weeks
  • 2\. Requiring CPAP with signs of early respiratory distress.
  • 3\. CPAP pressure of 5\-6 cm H2O and FiO2 \>\=0\.32, or a CPAP pressure 7\-8 cm H2O and FiO2 \>\=0\.28\.
  • 4\. Less than 12 hours of age.
  • 5\. Agreement of the Treating Physician in charge of the infant’s care.
  • 6\. Signed parental consent.

排除标准

  • 1\. Previously intubated, or in imminent need of intubation because of respiratory distress, apnoea or persistent acidosis.
  • 2\. Congenital anomaly or condition that might adversely affect breathing.
  • 3\. Identifiable alternative cause for respiratory distress (e.g. congenital pneumonia or pulmonary hypoplasia).
  • 4\. Lack of availability of an OPTIMIST treatment team.

结局指标

主要结局

未指定

相似试验